Skip to main content
OpenTrials

Clinical trial condition

Congenital Hearing Loss Secondary to Biallelic Mutations of the Otoferlin Gene (OTOF)

Explore clinical trials studying Congenital Hearing Loss Secondary to Biallelic Mutations of the Otoferlin Gene (OTOF). Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

Congenital Hearing Loss Secondary to Biallelic Mutations of the Otoferlin Gene (OTOF) trial results

Recruiting

A Study of DB-OTO, an Adeno-Associated Virus (AAV) Based Gene Therapy, in Children/Infants, Adolescents and Adults With Hearing Loss Due to Otoferlin Mutations

NCT05788536

Conditions
Auditory neuropathy, Congenital Hearing Loss Secondary to Biallelic Mutations of the Otoferlin Gene (OTOF), Deafness, Autosomal Recessive 9, +10 more
Locations
  • University of California Los Angeles Medical Center Los Angeles, California, United States
  • Rady Children's Hospital San Diego, California, United States
  • Nemours Children s Clinic Jacksonville, Florida, United States
  • Nemours Childrens Hospital Orlando, Florida, United States
View all 16 locations
View Trial Details

Related conditions